Interesting article...

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
It's probably becasue CHF is a relatively "easy" condition to treat if you follow the pretty simple SOC guidelines and patients dont really have a lot of control over the condition (unlike say DM which patients can make huge impacts in their care) so Pt interaction isn't that helpful

Also nice intro quote
Consultation with non-specialist pharmacists...

way to crap on non "clinical" pharmacist. Was this editing by APhA before it went to press?
 
Last edited:
It's probably becasue CHF is a relatively "easy" condition to treat if you follow the pretty simple SOC guidelines and patients do really have a lot of control over the condition (unlike say DM which patients can make huge impacts in their care) so Pt interaction isn't that helpful

Also nice intro quote


way to crap on non "clinical" pharmacist. Was this editing by APhA before it went to press?
Pharmacists place all their eggs into the evidence-based medicine basket. We do nothing other then follow logarithms. I think you have a point on something like this, its clear that with CHF, there isn't a lot of play in the therapy that logarithms in CHF. It would be interesting to know why they wanted to try with CHF.
 
Also if you go to the original article (not the link), one of the reported shortcomings of the study was an outcome performance based pay law was introduced the same year as the beginning of the study. I'm guessing this would lead more doctors to actually pay attention to proper indications, dosings, and guidelines.
 
Top